Sonoma Pharmaceuticals Inc (SNOA)
0.1599
0.00 (0.00%)
USD |
NASDAQ |
Apr 23, 16:00
0.1599
0.00 (0.00%)
After-Hours: 19:36
Sonoma Pharmaceuticals Profit Margin (Quarterly): -27.60% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -27.60% |
| September 30, 2023 | -54.34% |
| June 30, 2023 | -41.38% |
| March 31, 2023 | -43.40% |
| December 31, 2022 | -65.86% |
| September 30, 2022 | -30.53% |
| June 30, 2022 | -22.27% |
| March 31, 2022 | -128.1% |
| December 31, 2021 | -32.53% |
| September 30, 2021 | -2.67% |
| June 30, 2021 | -29.80% |
| March 31, 2021 | -169.7% |
| December 31, 2020 | -13.17% |
| September 30, 2020 | 2.08% |
| June 30, 2020 | 4.16% |
| March 31, 2020 | -40.26% |
| December 31, 2019 | -24.66% |
| September 30, 2019 | -25.45% |
| June 30, 2019 | 15.91% |
| March 31, 2019 | -73.53% |
| December 31, 2018 | -43.52% |
| September 30, 2018 | -57.10% |
| June 30, 2018 | -79.15% |
| March 31, 2018 | -130.3% |
| December 31, 2017 | -65.81% |
| Date | Value |
|---|---|
| September 30, 2017 | -66.36% |
| June 30, 2017 | -91.47% |
| March 31, 2017 | -60.46% |
| December 31, 2016 | |
| September 30, 2016 | -69.66% |
| June 30, 2016 | -97.35% |
| March 31, 2016 | -113.0% |
| December 31, 2015 | -126.8% |
| September 30, 2015 | -43.49% |
| June 30, 2015 | -63.59% |
| March 31, 2015 | -37.71% |
| December 31, 2014 | -183.8% |
| September 30, 2014 | -22.00% |
| June 30, 2014 | -2.06% |
| March 31, 2014 | |
| December 31, 2013 | -18.55% |
| September 30, 2013 | -34.21% |
| June 30, 2013 | -50.77% |
| March 31, 2013 | -73.31% |
| December 31, 2012 | -54.01% |
| September 30, 2012 | -33.56% |
| June 30, 2012 | 10.98% |
| March 31, 2012 | -52.76% |
| December 31, 2011 | -91.29% |
| September 30, 2011 | -22.90% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-169.7%
Minimum
Mar 2021
15.91%
Maximum
Jun 2019
-38.40%
Average
-29.80%
Median
Jun 2021
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -76.57% |
| Return on Assets | -34.16% |
| Return on Invested Capital | -74.41% |
| Gross Profit Margin (Quarterly) | 46.53% |
| Operating Margin (Quarterly) | -26.90% |
| Return on Net Operating Assets | -64.76% |